BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21632099)

  • 1. Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center.
    Bristow RE; Ueda S; Gerardi MA; Ajiboye OB; Ibeanu OA
    Gynecol Oncol; 2011 Aug; 122(2):319-23. PubMed ID: 21632099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in the treatment of advanced epithelial ovarian cancer.
    Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
    Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
    Dilley S; Erickson BK; Phillips CE; Kennemer CR; Zhang B; Matin T; Martin JY; Shah MM; Michael Straughn J; Leath CA
    Gynecol Oncol; 2018 Apr; 149(1):49-52. PubMed ID: 29605050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.
    Terplan M; Schluterman N; McNamara EJ; Tracy JK; Temkin SM
    Gynecol Oncol; 2012 Apr; 125(1):19-24. PubMed ID: 22108636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer.
    Du XL; Sun CC; Milam MR; Bodurka DC; Fang S
    Int J Gynecol Cancer; 2008; 18(4):660-9. PubMed ID: 17892451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites.
    Sakhuja S; Yun H; Pisu M; Akinyemiju T
    J Ovarian Res; 2017 Aug; 10(1):57. PubMed ID: 28830564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
    Bristow RE; Chang J; Ziogas A; Randall LM; Anton-Culver H
    Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type.
    Whitmore G; Ramzan A; Sheeder J; Guntupalli SR
    Int J Gynecol Cancer; 2020 Jul; 30(7):1018-1025. PubMed ID: 32107316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database.
    Beckmeyer-Borowko AB; Peterson CE; Brewer KC; Otoo MA; Davis FG; Hoskins KF; Joslin CE
    Cancer Causes Control; 2016 Oct; 27(10):1261-71. PubMed ID: 27590306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
    Rungruang BJ; Miller A; Krivak TC; Horowitz NS; Rodriguez N; Hamilton CA; Backes FJ; Carson LF; Friedlander M; Mutch DG; Goodheart MJ; Tewari KS; Wenham RM; Bookman MA; Maxwell GL; Richard SD
    Cancer; 2017 May; 123(6):985-993. PubMed ID: 27864921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.
    Brewer KC; Peterson CE; Davis FG; Hoskins K; Pauls H; Joslin CE
    Ann Epidemiol; 2015 Aug; 25(8):556-63. PubMed ID: 25986734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.
    Joslin CE; Brewer KC; Davis FG; Hoskins K; Peterson CE; Pauls HA
    Gynecol Oncol; 2014 Nov; 135(2):285-91. PubMed ID: 25173584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
    Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
    J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
    Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
    Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer.
    Terplan M; Temkin S; Tergas A; Lengyel E
    Gynecol Oncol; 2008 Nov; 111(2):173-8. PubMed ID: 18823649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Disparities in the Receipt of Guideline Care and Cancer Deaths for Women with Ovarian Cancer.
    Cronin KA; Howlader N; Stevens JL; Trimble EL; Harlan LC; Warren JL
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):539-545. PubMed ID: 30487136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities in survival in malignant germ cell tumors of the ovary.
    Hinchcliff E; Rauh-Hain JA; Clemmer JT; Diver E; Hall T; Stall J; Growdon W; Clark R; Schorge J
    Gynecol Oncol; 2016 Mar; 140(3):463-9. PubMed ID: 26773470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?
    Ross J; Braswell KV; Madeira da Silva L; Mujica F; Stutsman S; Finan MA; Nicolson W; Harmon MD; Missanelli M; Cohen A; Singh A; Scalici JM; Rocconi RP
    Gynecol Oncol; 2017 May; 145(2):329-333. PubMed ID: 28215839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer.
    Bian C; Yao K; Li L; Yi T; Zhao X
    Arch Gynecol Obstet; 2016 Jan; 293(1):163-168. PubMed ID: 26198168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.